Total Payments
$181,269
2024 Payments
$1,237
Companies
51
Transactions
794
Medicare Patients
26,426
Medicare Billing
$6.5M
Payment Breakdown by Category
Other$151,538 (83.6%)
Food & Beverage$13,912 (7.7%)
Travel$7,774 (4.3%)
Consulting$7,758 (4.3%)
Education$288.14 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $151,538 | 70 | 83.6% |
| Food and Beverage | $13,912 | 694 | 7.7% |
| Travel and Lodging | $7,774 | 15 | 4.3% |
| Consulting Fee | $7,758 | 8 | 4.3% |
| Education | $288.14 | 7 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $147,971 | 137 | $0 (2021) |
| Lilly USA, LLC | $21,562 | 27 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $1,814 | 125 | $0 (2023) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $1,541 | 89 | $0 (2024) |
| Abbott Laboratories | $779.46 | 19 | $0 (2024) |
| Amarin Pharma Inc. | $725.74 | 59 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $645.55 | 33 | $0 (2024) |
| Amgen Inc. | $645.00 | 33 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $451.19 | 21 | $0 (2023) |
| Novo Nordisk Inc | $443.76 | 23 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,237 | 41 | Abbott Laboratories ($391.36) |
| 2023 | $1,136 | 56 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($386.44) |
| 2022 | $1,367 | 86 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($292.88) |
| 2021 | $2,563 | 140 | Janssen Pharmaceuticals, Inc ($388.85) |
| 2020 | $7,576 | 87 | Lilly USA, LLC ($3,388) |
| 2019 | $52,797 | 140 | Boehringer Ingelheim Pharmaceuticals, Inc. ($35,195) |
| 2018 | $57,730 | 127 | Boehringer Ingelheim Pharmaceuticals, Inc. ($55,582) |
| 2017 | $56,862 | 117 | Boehringer Ingelheim Pharmaceuticals, Inc. ($54,423) |
All Payment Transactions
794 individual payment records from CMS Open Payments — Page 1 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: Heart Failure | ||||||
| 12/23/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $19.51 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/09/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $20.06 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $16.21 | General |
| Category: Cardiovascular | ||||||
| 11/13/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.23 | General |
| Category: Cardiovascular | ||||||
| 11/11/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $22.17 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/28/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $22.19 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/17/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $118.38 | General |
| 10/04/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Obesity | ||||||
| 09/16/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Cardiology | ||||||
| 09/15/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $24.19 | General |
| Category: Heart Failure and Hypertension | ||||||
| 09/09/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $20.18 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/04/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $69.75 | General |
| Category: Renal Denervation System | ||||||
| 08/26/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $18.87 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/14/2024 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 08/12/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $20.02 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/08/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $223.04 | General |
| Category: Heart Failure | ||||||
| 07/25/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $143.82 | General |
| Category: Heart Failure | ||||||
| 07/19/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.11 | General |
| Category: Cardiovascular | ||||||
| 07/08/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $19.40 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/03/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.41 | General |
| Category: Cardiovascular | ||||||
| 06/24/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $16.48 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 06/20/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $13.99 | General |
| Category: Cardiology | ||||||
| 06/10/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $18.96 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 06/03/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 43 | 6,300 | 9,223 | $7.1M | $1.6M |
| 2022 | 41 | 6,574 | 9,306 | $7.3M | $1.8M |
| 2021 | 40 | 6,106 | 8,461 | $4.7M | $1.5M |
| 2020 | 42 | 7,446 | 10,263 | $4.5M | $1.7M |
Total Patients
26,426
Total Services
37,253
Medicare Billing
$6.5M
Procedure Codes
174
All Medicare Procedures & Services
174 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78492 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress | Office | 2023 | 481 | 485 | $2.5M | $531,777 | 21.1% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2023 | 484 | 549 | $1.9M | $489,288 | 25.7% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 589 | 2,367 | $430,639 | $98,753 | 22.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 562 | 582 | $326,633 | $69,760 | 21.4% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 88 | 88 | $211,997 | $51,520 | 24.3% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 174 | 174 | $242,694 | $48,548 | 20.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 708 | 887 | $236,702 | $48,411 | 20.5% |
| 36223 | Insertion of tube into intracranial artery for diagnosis or treatment with review by radiologist | Office | 2023 | 23 | 23 | $193,995 | $39,779 | 20.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 357 | 392 | $149,505 | $34,846 | 23.3% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 666 | 670 | $137,900 | $30,469 | 22.1% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 125 | 125 | $112,244 | $25,271 | 22.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 183 | 183 | $88,886 | $21,541 | 24.2% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 47 | 48 | $81,125 | $20,496 | 25.3% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 133 | 134 | $71,466 | $16,097 | 22.5% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 174 | 177 | $36,750 | $11,743 | 32.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 181 | 181 | $60,598 | $11,214 | 18.5% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 71 | 535 | $40,973 | $9,955 | 24.3% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 63 | 264 | $26,633 | $6,906 | 25.9% |
| 93268 | Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring and review and report by health care professional | Office | 2023 | 52 | 52 | $28,616 | $5,717 | 20.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 95 | 99 | $21,149 | $4,435 | 21.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 388 | 408 | $17,179 | $3,714 | 21.6% |
| 93459 | Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | Facility | 2023 | 16 | 16 | $15,440 | $3,461 | 22.4% |
| 93975 | Complete ultrasound of abdomen and pelvis artery and vein blood flow | Office | 2023 | 20 | 20 | $14,894 | $3,385 | 22.7% |
| 78473 | Nuclear medicine studies of heart pumping function by labeling red blood cells with measurement of internal blood volume ejected with every beat over multiple cycles | Office | 2023 | 16 | 16 | $12,290 | $2,985 | 24.3% |
| A9560 | Technetium tc-99m labeled red blood cells, diagnostic, per study dose, up to 30 millicuries | Office | 2023 | 19 | 19 | $9,017 | $2,880 | 31.9% |
About Dr. Marcus Smith, MD
Dr. Marcus Smith, MD is a Internal Medicine healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/22/2007. The National Provider Identifier (NPI) number assigned to this provider is 1578769055.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marcus Smith, MD has received a total of $181,269 in payments from pharmaceutical and medical device companies, with $1,237 received in 2024. These payments were reported across 794 transactions from 51 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($151,538).
As a Medicare-enrolled provider, Smith has provided services to 26,426 Medicare beneficiaries, totaling 37,253 services with total Medicare billing of $6.5M. Data is available for 4 years (2020–2023), covering 174 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Interventional Cardiology, Cardiovascular Disease
- Location Oklahoma City, OK
- Active Since 06/22/2007
- Last Updated 03/13/2017
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1578769055
Products in Payments
- JARDIANCE (Drug) $168,489
- XARELTO (Drug) $1,814
- LifeVest (Device) $1,541
- PRADAXA (Drug) $1,044
- Vascepa (Drug) $725.74
- ELIQUIS (Drug) $407.80
- Corlanor (Drug) $398.25
- CARDIOMEMS (Device) $391.36
- VERQUVO (Drug) $373.75
- BRILINTA (Drug) $344.47
- Ozempic (Drug) $279.08
- CAMZYOS (Drug) $261.99
- Glidesheath (Device) $250.00
- ENTRESTO (Drug) $249.32
- Repatha (Biological) $246.75
- NEXLIZET (Drug) $219.74
- Supera peripheral stent system (Device) $194.24
- NORTHERA (Drug) $179.07
- Barostim Neo System (Device) $175.27
- Advisa (Device) $166.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Oklahoma City
John Kingrey, Md, MD
Internal Medicine — Payments: $325,421
Internal Medicine $325,421
Dr. Jeffrey Sparling, M.d, M.D
Internal Medicine — Payments: $289,451
Internal Medicine $289,451
Dr. Romeo Mandanas, M.d, M.D
Internal Medicine — Payments: $275,924
Internal Medicine $275,924
Dr. Ryan Morgan, D.o, D.O
Internal Medicine — Payments: $126,341
Internal Medicine $126,341
Usman Baber, Md, MD
Internal Medicine — Payments: $76,000
Internal Medicine $76,000
Dr. Krittapoom Akrawinthawong, M.d, M.D
Internal Medicine — Payments: $74,128
Internal Medicine $74,128